US FDA declines approval for Novartis’ inclisiran Reuters Dec 19, 2020 The drug regulator cited unresolved facility inspection issues for denying approval
Novartis analysis shows inclisiran lowers LDL-C with high consistency EP News Bureau Aug 30, 2020 The analysis evaluated the efficacy and tolerability of inclisiran on top of a maximally tolerated dose of statins, in two studies…
